...
首页> 外文期刊>Auris, nasus, larynx >Levocabastine nasal spray significantly improves perennial allergic rhinitis: a single-blind placebo-controlled study.
【24h】

Levocabastine nasal spray significantly improves perennial allergic rhinitis: a single-blind placebo-controlled study.

机译:莱卡巴巴汀鼻喷雾剂可显着改善常年性变应性鼻炎:单盲安慰剂对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The efficacy of levocabastine nasal spray for relieving the symptoms of perennial allergic rhinitis was compared with placebo in a single-blind study. METHODS: Three hundred and thirty-five patients with moderate to severe perennial allergic rhinitis were randomized to three groups that were administered a high or low dose of levocabastine nasal spray or a placebo. Patients were not informed of their treatment. Efficacy was evaluated based on the changes of symptoms and rhinoscopy findings. RESULTS: Significant improvement of symptoms was observed in both the high-dose and low-dose levocabastine groups compared with the placebo group. There were no significant differences of efficacy between the high-dose and low-dose levocabastine groups. There was also no significant difference in the occurrence of adverse effects among the three groups. CONCLUSION: Levocabastine nasal spray is a safe and effective treatment for perennial allergic rhinitis.
机译:目的:在单盲研究中比较了左旋卡泊汀鼻喷雾剂与安慰剂的缓解常年性变应性鼻炎症状的疗效。方法:将335例中度至重度常年性变应性鼻炎患者随机分为三组,分别接受高剂量或低剂量的左卡巴汀鼻喷雾剂或安慰剂。没有告知患者治疗方法。根据症状的变化和鼻镜检查结果评估疗效。结果:与安慰剂组相比,高剂量和低剂量左卡巴汀组的症状均有明显改善。高剂量和低剂量左卡巴汀组之间的疗效没有显着差异。三组之间不良反应的发生率也没有显着差异。结论:莱卡巴巴汀鼻喷雾剂治疗多年生变应性鼻炎是一种安全有效的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号